Aoxing Pharmaceutical Co., Inc. (AXN) Reports Q1 Loss of $0.02

Aoxing Pharmaceutical Co., Inc. (NYSE: AXN) reported Q1 EPS of ($0.02), versus ($0.01) reported last year. Revenue for the quarter came in at $1.53 million, versus $1.74 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• Dollar General (DG) Tops Q2 EPS by 48c, Beats on Revenue; Offers FY27 EPS Guidance
• Autodesk (ADSK) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY27 EPS Guidance